title: [Pathology, physiopathology, diagnosis of paraneoplastic neurological syndromes and the treatment strategy (discussion)].
authors.forename: Takashi
authors.initials: T
authors.lastname: Inuzuka
authors.forename: Michihito
authors.initials: M
authors.lastname: Masuda
authors.forename: Takeo
authors.initials: T
authors.lastname: Sakurai
authors.forename: Hiide
authors.initials: H
authors.lastname: Yoshino
authors.forename: Naoki
authors.initials: N
authors.lastname: Hattori
mesh_terms: D000912:Antibodies, Neoplasm; D001323:Autoantibodies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D009419:Nerve Tissue Proteins / Q000276:immunology; D009420:Nervous System / Q000276:immunology; D020361:Paraneoplastic Syndromes, Nervous System / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D020551:Pulse Therapy, Drug; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
chemical_list: D000912:Antibodies, Neoplasm; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D009419:Nerve Tissue Proteins; D008775:Methylprednisolone